OBJECTIVES The goal of this prospective study was to evaluate the carotid atherosclerosis score (CAS) for predicting the development of high-risk plaque features and plaque burden progression. BACKGROUND Previous studies have shown that carotid intraplaque hemorrhage (IPH) and a disrupted luminal surface (DLS), as identified by using magnetic resonance imaging, are associated with greater risk for cerebrovascular events. On the basis of data from a large cross-sectional study, a scoring system was developed to determine which plaque features are associated with the presence of IPH and DLS. However, the predictive value of CAS has not been previously tested in a prospective, longitudinal study. METHODS A total of 120 asymptomatic subjects with 50% to 79% carotid stenosis underwent carotid magnetic resonance imaging scans at baseline and 3 years thereafter. Presence of IPH and DLS, wall volume, maximum wall thickness, and maximum percent lipid-rich necrotic core area were measured at both time-points. Baseline CAS values were calculated on the basis of previously published criteria. RESULTS Of the 73 subjects without IPH or DLS at baseline, 9 (12%) developed 1 or both of these features during follow-up. There was a significant increasing trend between CAS and the development of new DLS (p < 0.001) and with plaque burden progression (p = 0.03) but not with the development of new IPH (p = 0.3). Percent carotid stenosis was not significantly associated with new DLS (p = 0.2), new IPH (p = 0.1), or plaque progression (p = 0.6). CONCLUSIONS CAS was found to have a significant increasing relationship with incident DLS and plaque progression in this prospective study. CAS can potentially provide improved risk stratification beyond lumina! stenosis. (C) 2014 by the American College of Cardiology Foundation
基金:
National Heart, Lung and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL061851, R01HL073401, R01HL67406, T32HL7838]; Philips Healthcare; GE HealthcareGE Healthcare; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; VPDiagnostics
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类|2 区医学
小类|1 区核医学2 区心脏和心血管系统
最新[2023]版:
大类|1 区医学
小类|1 区心脏和心血管系统1 区核医学
JCR分区:
出版当年[2012]版:
Q1CARDIAC & CARDIOVASCULAR SYSTEMSQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2023]版:
Q1CARDIAC & CARDIOVASCULAR SYSTEMSQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者机构:[1]Univ Washington, Dept Radiol, Seattle, WA 98109 USA;
通讯作者:
通讯机构:[6]Univ Washington, Dept Surg, Seattle, WA 98109 USA;[7]Univ Washington, Vasc Imaging Lab, 850 Republ St,Box 358050, Seattle, WA 98109 USA
推荐引用方式(GB/T 7714):
Xu Dongxiang,Hippe Daniel S.,Underhill Hunter R.,et al.Prediction of High-Risk Plaque Development and Plaque Progression With the Carotid Atherosclerosis Score[J].JACC-CARDIOVASCULAR IMAGING.2014,7(4):366-373.doi:10.1016/j.jcmg.2013.09.022.
APA:
Xu, Dongxiang,Hippe, Daniel S.,Underhill, Hunter R.,Oikawa-Wakayama, Minako,Dong, Li...&Hatsukami, Thomas S..(2014).Prediction of High-Risk Plaque Development and Plaque Progression With the Carotid Atherosclerosis Score.JACC-CARDIOVASCULAR IMAGING,7,(4)
MLA:
Xu, Dongxiang,et al."Prediction of High-Risk Plaque Development and Plaque Progression With the Carotid Atherosclerosis Score".JACC-CARDIOVASCULAR IMAGING 7..4(2014):366-373